Atara Biotherapeutics (ATRA) Work In Process (2022 - 2024)
Atara Biotherapeutics' (ATRA) quarterly Work In Process came in at $9.7 million in Q4 2024, up 31.47% YoY from $7.4 million in Q1 2024, and down 21.39% on a QoQ basis from $12.3 million in Q3 2024.
Atara Biotherapeutics (ATRA) Work In Process (2022 - 2024) Analysis & Trends
Atara Biotherapeutics (ATRA) has 3 years of Work In Process data on file, last reported at $9.7 million in Q4 2024.
- Quarterly Work In Process rose 31.47% year-over-year to $9.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $9.7 million (up 31.47% YoY) and the FY2024 annual result came in at $9.7 million, up 31.47% from the prior year.
- Work In Process retreated to $9.7 million in Q4 2024, from $12.3 million in the prior quarter.
- In the past five years, Work In Process ranged from a high of $15.1 million in Q2 2024 to a low of $372000.0 in Q4 2022.
- A 3-year average of $7.8 million and a median of $7.4 million in 2023 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2023 — Work In Process surged 1881.45% — and 2024, when it jumped 31.47%.
- Tracing ATRA's Work In Process over 3 years: stood at $372000.0 in 2022, then surged by 1881.45% to $7.4 million in 2023, then jumped by 31.47% to $9.7 million in 2024.
- The last three Work In Process figures came in at $9.7 million (Q4 2024), $12.3 million (Q3 2024), and $15.1 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - |
| 10 | Atara Biotherapeutics | 140.11 Mn | 123.56 Mn | 439,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 9.69 Mn |
| Sep 30, 2024 | 12.33 Mn |
| Jun 30, 2024 | 15.11 Mn |
| Mar 31, 2024 | 11.72 Mn |
| Dec 31, 2023 | 7.37 Mn |
| Sep 30, 2023 | 4.17 Mn |
| Jun 30, 2023 | 5.11 Mn |
| Mar 31, 2023 | 4.02 Mn |
| Dec 31, 2022 | 372,000.00 |